Abbvie (ABBV) PT Raised to $215 at BMO Capital as 'Guidance Raise Gives More Confidence'
Tweet Send to a Friend
BMO Capital analyst Evan David Seigerman raised the price target on Abbvie (NYSE: ABBV) to $215.00 (from $208.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
